Medigene AG
MDGEF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $31 | $48 | $65 | $85 |
| - Cash | $9 | $22 | $22 | $30 |
| + Debt | $3 | $4 | $4 | $5 |
| Enterprise Value | $25 | $29 | $47 | $60 |
| Revenue | $6 | $31 | $10 | $8 |
| % Growth | -80.7% | 198.6% | 30.8% | – |
| Gross Profit | $4 | $7 | $6 | $0 |
| % Margin | 72.8% | 23.7% | 54.2% | 3% |
| EBITDA | -$15 | $13 | -$7 | -$22 |
| % Margin | -256% | 42% | -62.2% | -269.1% |
| Net Income | -$16 | -$8 | -$10 | -$29 |
| % Margin | -268.1% | -26.7% | -95.4% | -360.8% |
| EPS Diluted | -1.32 | -0.64 | -0.77 | -2.23 |
| % Growth | -106.3% | 16.9% | 65.5% | – |
| Operating Cash Flow | -$15 | $12 | -$11 | -$25 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | -$16 | $11 | -$11 | -$25 |